This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Keiichi Murakami and a More Efficient Route to a Pyridine Intermediate.
Introduction
Keiichi Murakami is an inventor associated with Eisai R&D Management Co., Ltd., based in Kamisu, Japan. His patent work includes a production method for a synthetic intermediate used in the development of E7090, an FGFR inhibitor.
Latest Patents
Murakami is named on 1 patent, titled “Production method for synthetic intermediate of monocyclic pyridine derivative.” The invention describes a process designed to produce key intermediates, compound (2i) or its salt and compound (1g), with improved yield and efficiency. These intermediates are used in the production of E7090.
Career Highlights
The patent reflects Murakami’s contribution to pharmaceutical process development at Eisai R&D Management Co., Ltd. Its focus is on improving the synthesis of compounds that support the production of a potential therapeutic agent.
Collaborations
Mitsuo Nagai and Takashi Fukuyama are identified as Murakami’s coworkers. Their shared association with the patent points to collaborative work on the synthetic process.
Conclusion
Keiichi Murakami’s patent documents a more efficient approach to producing key intermediates for E7090, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile